Nothing Special   »   [go: up one dir, main page]

NO20000466L - Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering - Google Patents

Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering

Info

Publication number
NO20000466L
NO20000466L NO20000466A NO20000466A NO20000466L NO 20000466 L NO20000466 L NO 20000466L NO 20000466 A NO20000466 A NO 20000466A NO 20000466 A NO20000466 A NO 20000466A NO 20000466 L NO20000466 L NO 20000466L
Authority
NO
Norway
Prior art keywords
self
acidic
pharmaceutically acceptable
pharmaceutical preparation
composition
Prior art date
Application number
NO20000466A
Other languages
English (en)
Other versions
NO323425B1 (no
NO20000466D0 (no
Inventor
Walter Morozowich
Ping Gao
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20000466D0 publication Critical patent/NO20000466D0/no
Publication of NO20000466L publication Critical patent/NO20000466L/no
Publication of NO323425B1 publication Critical patent/NO323425B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Cosmetics (AREA)
NO20000466A 1997-07-29 2000-01-28 Farmasoytisk preparat omfattende en pyranonforbindelse, og emulsjoner eller kapsler inbefattende preparatet NO323425B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5401297P 1997-07-29 1997-07-29
PCT/US1998/014817 WO1999006044A1 (en) 1997-07-29 1998-07-27 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation

Publications (3)

Publication Number Publication Date
NO20000466D0 NO20000466D0 (no) 2000-01-28
NO20000466L true NO20000466L (no) 2000-03-28
NO323425B1 NO323425B1 (no) 2007-04-30

Family

ID=21988155

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000466A NO323425B1 (no) 1997-07-29 2000-01-28 Farmasoytisk preparat omfattende en pyranonforbindelse, og emulsjoner eller kapsler inbefattende preparatet

Country Status (25)

Country Link
US (1) US6231887B1 (no)
EP (1) EP0989851B1 (no)
JP (1) JP4524367B2 (no)
KR (1) KR100509131B1 (no)
CN (1) CN1112927C (no)
AT (1) ATE225174T1 (no)
AU (1) AU728626B2 (no)
BR (1) BR9810729B1 (no)
CA (1) CA2294033C (no)
CY (1) CY2006002I2 (no)
CZ (1) CZ296957B6 (no)
DE (1) DE69808463T2 (no)
DK (1) DK0989851T3 (no)
ES (1) ES2184310T3 (no)
FI (1) FI20000172A (no)
HK (1) HK1028879A1 (no)
HU (1) HU228923B1 (no)
NO (1) NO323425B1 (no)
NZ (1) NZ502566A (no)
PL (1) PL192865B1 (no)
PT (1) PT989851E (no)
RU (1) RU2202346C2 (no)
SI (1) SI0989851T1 (no)
SK (1) SK284616B6 (no)
WO (1) WO1999006044A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
WO2000057885A1 (en) * 1999-03-31 2000-10-05 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
YU32103A (sh) * 2000-10-31 2006-05-25 Boehringer Ingelheim Pharmaceuticals Inc. Samo-emulgujući preparati za oralnu primenu piranonskih inhibitora proteaze
SE0102993D0 (sv) * 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
MXPA04007438A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
US6828301B2 (en) 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
EP1613353A1 (en) * 2003-04-02 2006-01-11 Boehringer Ingelheim International GmbH Pharmaceutical compositions for hepatitis c viral protease inhibitors
WO2005011635A2 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
CA2541398C (en) * 2003-10-07 2012-08-21 Eli Lilly And Company Liquid formulations of ractopamine
JP2008520701A (ja) * 2004-11-19 2008-06-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チプラナビル及びレバーセットの同時投与を介したｈｉｖ感染症の治療方法
US20060122220A1 (en) * 2004-11-19 2006-06-08 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and UK-427,857
WO2006060159A1 (en) * 2004-12-01 2006-06-08 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and gw695634
JP5028885B2 (ja) * 2006-07-04 2012-09-19 大正製薬株式会社 ユビデカレノン含有自己乳化組成物
AU2008226823B2 (en) 2007-03-12 2014-03-13 Nektar Therapeutics Oligomer-protease inhibitor conjugates
EP2262538B1 (en) * 2008-03-12 2014-12-10 Nektar Therapeutics Oligomer-amino acid conjugate
JP2012530069A (ja) 2009-06-12 2012-11-29 ネクター セラピューティックス プロテアーゼ阻害剤、水溶性非ペプチドオリゴマーおよび親油性部分を含む共有結合体
BR112012000287B8 (pt) * 2009-07-07 2021-05-25 Boehringer Ingelheim Int composição farmacêutica para um inibidor de protease viral de hepatite c
JP5951489B2 (ja) 2009-10-16 2016-07-13 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ 組成物
RU2419426C1 (ru) * 2010-04-26 2011-05-27 Всеволод Иванович Киселев Лекарственное средство на основе дииндолилметана (dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека
KR101752944B1 (ko) 2010-05-03 2017-07-03 테이코쿠 팔마 유에스에이, 인코포레이티드 비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
AU2014204739B2 (en) * 2013-01-14 2016-08-11 Infirst Healthcare Limited Compositions and methods for treating severe pain

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230702A (en) 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
DE3300793A1 (de) * 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
GB8903804D0 (en) 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US5071643A (en) 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
IL102236A0 (en) * 1991-06-27 1993-01-14 Ltt Inst Co Ltd Topical preparations containing cyclosporin
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
GB9208712D0 (en) * 1992-04-22 1992-06-10 Sandoz Ltd Pharmaceutical compositions containing cyclosporin derivates
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
AU2999995A (en) * 1994-07-22 1996-02-22 G.D. Searle & Co. Self-emulsifying drug delivery system
WO1996033697A1 (fr) * 1995-04-24 1996-10-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Formulation auto-emulsionnable formant une emulsion huile dans l'eau
CN1092960C (zh) 1995-06-06 2002-10-23 霍夫曼-拉罗奇有限公司 含蛋白酶抑制剂和单酸甘油酯的药物组合物
ZA9710071B (en) * 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.

Also Published As

Publication number Publication date
US6231887B1 (en) 2001-05-15
HK1028879A1 (en) 2001-03-09
RU2202346C2 (ru) 2003-04-20
JP4524367B2 (ja) 2010-08-18
JP2002510330A (ja) 2002-04-02
EP0989851A1 (en) 2000-04-05
CN1261796A (zh) 2000-08-02
CZ296957B6 (cs) 2006-08-16
NZ502566A (en) 2002-03-28
CZ2000156A3 (cs) 2000-05-17
AU8573898A (en) 1999-02-22
CA2294033C (en) 2007-01-09
HU228923B1 (en) 2013-06-28
HUP0002440A2 (hu) 2001-09-28
CA2294033A1 (en) 1999-02-11
BR9810729A (pt) 2000-08-08
SI0989851T1 (en) 2003-04-30
SK162000A3 (en) 2000-12-11
NO323425B1 (no) 2007-04-30
KR20010022369A (ko) 2001-03-15
ATE225174T1 (de) 2002-10-15
PL192865B1 (pl) 2006-12-29
ES2184310T3 (es) 2003-04-01
CY2006002I2 (el) 2012-01-25
DE69808463D1 (de) 2002-11-07
NO20000466D0 (no) 2000-01-28
DK0989851T3 (da) 2003-01-27
EP0989851B1 (en) 2002-10-02
PT989851E (pt) 2002-12-31
HUP0002440A3 (en) 2001-10-29
WO1999006044A1 (en) 1999-02-11
KR100509131B1 (ko) 2005-08-18
DE69808463T2 (de) 2003-06-26
CY2006002I1 (el) 2011-02-02
AU728626B2 (en) 2001-01-11
SK284616B6 (sk) 2005-07-01
PL338335A1 (en) 2000-10-23
BR9810729B1 (pt) 2010-07-13
FI20000172A (fi) 2000-01-28
CN1112927C (zh) 2003-07-02

Similar Documents

Publication Publication Date Title
NO20000466L (no) Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
PT999838E (pt) Formulacao auto-emulsionante para compostos lipofilicos
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
HUP0500843A2 (hu) Fokozott biológiai hasznosulású, szájon át hatásos taxánszármazékokat tartalmazó gyógyszerkészítmények
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
HUP0301972A2 (hu) Fentanilszerű szerkezetű opioidot és ketamint tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmény
ATE287408T1 (de) Tricyclische derivate der pyrazolcarbonsäure, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
CA2294031A1 (en) SELF-EMULSIFYING FORMULATION FOR LIPOPHILIC COMPOUNDS
EE03471B1 (et) Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine
EP0882450A3 (en) Cholesterol-lowering composition comprising coenzyme Q
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
PT1078627E (pt) Formulacao farmaceutica compreendendo amoxicilina e clavulanato
PT911026E (pt) Derivados da creatina para a asma
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
NO950177D0 (no) Farmakologisk aktive erivater
SE0002354D0 (sv) New formulation
TH77238A (th) สารสูตรผสมที่คล้ายกับไซโคลสปอริน

Legal Events

Date Code Title Description
MK1K Patent expired